Call centers live at the heart of healthcare communication. But, all call centers are probably the most disliked aspect of the business from both sides of the table.
Everyone in the pharmaceutical industry wants to enhance and personalize patient engagement while also lowering costs and reducing the risk of the unknown when it comes to breaking into a new market.
It goes without saying, that clinical trials are an incredibly important aspect of the pharmaceutical industry as a whole. But, unfortunately, they are the furthest thing from inexpensive or easy to manage.
What is driving pharma to the cloud? Sure, it is value-driven, geared to consumers, specifically patients, who take active roles in their health care and want information at their fingertips instead of waiting for it to trickle down through the maze of doctors, tests, and procedures. And yes, it's driven by constantly changing healthcare regulations, finances, digital initiation, and integration. It's also driven by individual companies that want more efficient ways to gather, disseminate and manage their patient data.
Driving pharma to the cloud is value-driven and geared to patients who take active roles in their healthcare. Specifically, those who want information at their fingertips. Instead, of waiting for it to trickle down through the maze of doctors, tests, and procedures.
It's also driven by constantly changing health care regulations, finances, digital initiation, integration, and individual companies that want more efficient ways to manage their patient data.
Will public clouds be too risky? Will private clouds be safe? What about a hybrid of the two?
While you're analyzing the risks and benefits that the cloud might bring to your organization, consider the network availability. Performance and security are key players in those driving forces that help enterprises choose a cloud infrastructure.
Anupam Nandwana | January 9, 2018
Avirup Basu | June 7, 2018
Swapan Kumar Manna | May 20, 2018
Anupam Nandwana | October 6, 2017
Anupam Nandwana | March 8, 2018